Vanguard Group Inc Tempest Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
28Shares Held
2.04MCall Options Held
42.8KPut Options Held
72.9K-
Black Rock Inc. New York, NY550KShares$3.77 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA433KShares$2.97 Million0.0% of portfolio
-
Ubs Group Ag324KShares$2.22 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA115KShares$784,7290.0% of portfolio
-
Northern Trust Corp Chicago, IL99.4KShares$680,8280.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $71.4M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...